Midodrine as adjunctive support for treatment of refractory hypotension in the intensive care unit: a multicenter, randomized, placebo controlled trial (the MIDAS trial)

Peer Review reports

Original Submission
23 Jan 2017	Submitted	Original manuscript
24 Jan 2017	Author responded	Author comments - Matthew Anstey
Resubmission - Version 2
24 Jan 2017	Submitted	Manuscript version 2
25 Feb 2017	Reviewed	Reviewer Report - Jun Lin
2 Mar 2017	Author responded	Author comments - Matthew Anstey
Resubmission - Version 3
2 Mar 2017	Submitted	Manuscript version 3
5 Mar 2017	Reviewed	Reviewer Report - Jun Lin
Resubmission - Version 4
	Submitted	Manuscript version 4
Publishing
13 Mar 2017	Editorially accepted
21 Mar 2017	Article published	10.1186/s12871-017-0339-x

Back to article page